Researchers have been excited about this new drug, a innovative dual agonist showing remarkable results in early trials for weight loss . It works by modulating both pathways : GLP-1 and GIP, these, when engaged , support regulate hunger and improve energy expenditure . Initial reports indicate noteworthy body management and potential improvements